Heterologous expression of P9 from Akkermansia muciniphila increases the GLP-1 secretion of intestinal L cells
Glucagon-like peptide-1(GLP-1) is an incretin hormone secreted primarily from the intestinal L-cells in response to meals. GLP-1 is a key regulator of energy metabolism and food intake. It has been proven that P9 protein from A. muciniphila could increase GLP-1 release and improve glucose homeostasi...
Gespeichert in:
Veröffentlicht in: | World journal of microbiology & biotechnology 2024-07, Vol.40 (7), p.199-199, Article 199 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Glucagon-like peptide-1(GLP-1) is an incretin hormone secreted primarily from the intestinal L-cells in response to meals. GLP-1 is a key regulator of energy metabolism and food intake. It has been proven that P9 protein from
A. muciniphila
could increase GLP-1 release and improve glucose homeostasis in HFD-induced mice. To obtain an engineered
Lactococcus lactis
which produced P9 protein, mature polypeptide chain of P9 was codon-optimized, fused with N-terminal signal peptide Usp45, and expressed in
L. lactis
NZ9000. Heterologous secretion of P9 by recombinant
L. lactis
NZP9 were successfully detected by SDS-PAGE and western blotting. Notably, the supernatant of
L. lactis
NZP9 stimulated GLP-1 production of NCI-H716 cells. The relative expression level of GLP-1 biosynthesis gene
GCG
and
PCSK1
were upregulated by 1.63 and 1.53 folds, respectively. To our knowledge, this is the first report on the secretory expression of carboxyl-terminal processing protease P9 from
A. muciniphila
in
L. lactis.
Our results suggest that genetically engineered
L. lactis
which expressed P9 may have therapeutic potential for the treatment of diabetes, obesity and other metabolic disorders. |
---|---|
ISSN: | 0959-3993 1573-0972 1573-0972 |
DOI: | 10.1007/s11274-024-04012-z |